Aristopharma Ltd Job Circular 2022

The Aristopharma Ltd recently announced a vacancy for Bangladeshi graduates or People. Welcome to the Aristopharma Ltd job circular Updates. As you know, The Aristopharma Ltd started its journey in 1986 with the honest promise to provide quality medicines at affordable prices to the countrymen. Its state-of-the-art manufacturing plant, located at Shampur, Kadamtali -Dhaka, is equipped with highly sophisticated and advanced facilities. It is a Pharmaceutical Job circular. Therefore, having a position in this company is an excellent opportunity for you. Here you will find the latest Aristopharma Ltd job circular 2022 along with the salary and other requirements.

Aristopharma conducted a bioequivalence study for its products like Omep (Omeprazole) Capsule, Meta card MR (Trimetazidine) Tablet, Lodipin-5 (Amlodipine) Tablet, AZ (Azithromycin) Capsule & Suspension, Aeroplan (Meropenem) Injection, etc. The company also conducted clinical trials on Taxetil (Cefpodoxime), Affix (Cefixime), Meta card MR (Trimetazidine), and Ipec-Plus (Iron Polymaltose+Zinc+Folic Acid), etc. and the results of these studies showed that they are as effective as innovators’ brands. It may be mentioned that clinical trials on some other products are ongoing at different hospitals and universities.

With the aim to cope with the challenges of globalization, Aristopharma ltd. stepped beyond the boundary of Bangladesh in 2000, Vietnam being the first country to export. Today Aristopharma exports its quality medicines to 30 countries on 5 continents and is moving aggressively to expand and extend its export market.

Aristopharma Ltd”- one of the Top Pharmaceutical companies in the country, is seeking applications from competent, dynamic, dedicated, and self-motivated persons who want to have a career in corporate to fill up the following position.

Aristopharma Ltd Job Circular Updates 2022:

If you are looking for the latest Aristopharma Ltd job circular 2022, then you are in the right place. Here we have shared the job details along with salary and location. Also, we have included the official Aristopharma Ltd vacancy announcement. Read the circular carefully, and apply to Aristopharma Ltd as soon as possible if you fulfill the job criteria.

  • Organization: Aristopharma Ltd
  • Job Role: See the Circular Image
  • Salary: See the Circular Image
  • Employment Status: Full-time
  • Job Type: Pharmaceutical Job
  • Education Requirements: See the Circular Image
  • Experience: See the Circular Image
  • Age Limit: See the Circular Image
  • Job Location: See the Circular Image
  • Number of Vacancies: See the Circular Image
  • Additional Requirements: See the Circular Image
  • Selection Procedure: Viva
  • Published on: 16 April 2022
  • Deadline:  18 – 21 April 2022
  • Official Website: aristopharma.com

Aristopharma Ltd Job Circular 2022 Official Image:

Aristopharma Ltd Job Circular April 2022

How to Apply for Aristopharma Ltd Job Circular?

The candidates, fulfilling the above requirements, are requested to apply to:

Online Application:  See The Circular Image

You may also apply:

Contact Address of Aristopharma Ltd:

Head Office:

  • Address: Purana Paltan Line
  • 1000, Bangladesh
  • E-mail: apl@aristopharma.com

Aristopharma Ltd contact number:

  • Official Phone Number: 02-9351693

Conclusion: Aristopharma Ltd is a prominent organization in the country employing hundreds of Bangladeshi people. Also, Aristopharma Ltd is contributing significantly to the country’s economy. No need for more words about the Aristopharma Ltd Job circular full information in this post. If you want the updated Circular of Aristopharma Ltd, then bookmark the BDjobsFeed.com to find similar jobs along with other different career opportunities. Moreover, if you have graduated recently and have no experience, then our updated job circulars will help you to find your first career. If you have any questions or complaints, just place a comment below. Thanks for being with us.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments